Inventor · Berlin, DE

Frank Osterkamp

23Patents
5h-index
41Co-inventors
65Inventor score

Filing activity: Mar 24, 2005 → Jul 8, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8450275B2 TFPI inhibitors and methods of use Physics 12 Active
US10201586B2 TFPI inhibitors and methods of use Physics 10 Active
US10800816B2 TFPI inhibitors and methods of use Physics 10 Active
US8546523B2 NPR-B agonists Chemistry; Metallurgy 6 Active
US9169293B2 NPR-B agonists Chemistry; Metallurgy 5 Active
US8029979B2 Method for determining the substrate specificity of an enzyme Chemistry; Metallurgy 4 Active
US9018167B2 TFPI inhibitors and methods of use Physics 3 Active
US10799605B2 Conjugate comprising a neurotensin receptor ligand and use thereof Human Necessities 3 Active
US8962563B2 TFPI inhibitors and methods of use Physics 3 Active
US9745344B2 NPR-B agonists Chemistry; Metallurgy 3 Active
US9447147B2 Peptides and methods of use Chemistry; Metallurgy 2 Active
US8927534B2 Compounds for the inhibition of integrins and use thereof Chemistry; Metallurgy 2 Active
US10961199B2 Neurotensin receptor ligands Chemistry; Metallurgy 2 Active
US8309735B2 Heterocyclic compounds for the inhibition of integrins and use thereof Chemistry; Metallurgy 2 Active
US9873720B2 TFPI inhibitors and methods of use Physics 1 Active
US9982016B2 NPR-B agonists Chemistry; Metallurgy 1 Active
US9556230B2 TFPI inhibitors and methods of use Physics 1 Active
US10124033B2 Peptides and methods of use Chemistry; Metallurgy 0 Active
US9458198B1 Cyclic peptide-based NPR-B agonists Chemistry; Metallurgy 0 Active
US11793855B2 TFPI inhibitors and methods of use Physics 0 Active
US12427210B2 Compounds comprising a fibroblast activation protein ligand and use thereof Human Necessities 0 Active
US10196423B2 NPR-B agonists Chemistry; Metallurgy 0 Active
US8501787B2 Compounds for the inhibition of angiogenesis and use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.